141 related articles for article (PubMed ID: 37901324)
1. The outcome of acute leukemia patients with SET-NUP214 fusion after allogeneic stem cell transplantation.
Shen Y; Yang D; Zhang R; Chen X; Ma Q; Wei J; Zhai W; Pang A; He Y; Jiang E; Feng S
Front Oncol; 2023; 13():1256043. PubMed ID: 37901324
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].
Chen SM; Song WJ; Qin YZ; Wang Z; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Huang XJ; Lai YY
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):459-465. PubMed ID: 34384151
[No Abstract] [Full Text] [Related]
3. [Allogeneic hematopoietic stem cell transplantation in acute leukemia patients with the SET-NUP214 fusion gene: Efficacy and survival analysis].
Xia J; Zhao Y; Chen F; Miao M; Qiu HY; Ma X; Tang XW; Wang Y; Wu XJ; Fu ZZ; Wu DP; Chen SN
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):410-415. PubMed ID: 37032136
[No Abstract] [Full Text] [Related]
4. [Clinical Analysis of
Song Y; Gong XY; Wei SN; Li QH; Zhang GJ; Wang Y; Wei H; Lin D; Li SZ; Feng SZ; Wang JX; Mi YC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):352-357. PubMed ID: 37096505
[TBL] [Abstract][Full Text] [Related]
5. The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.
Wang J; Zhan QR; Lu XX; Zhang LJ; Wang XX; Zhang HY
Medicine (Baltimore); 2022 Jul; 101(30):e29294. PubMed ID: 35905214
[TBL] [Abstract][Full Text] [Related]
6. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines.
Quentmeier H; Schneider B; Röhrs S; Romani J; Zaborski M; Macleod RA; Drexler HG
J Hematol Oncol; 2009 Jan; 2():3. PubMed ID: 19166587
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of SET-NUP214 fusion gene in acute leukemia after allogeneic hematopoietic stem cell transplantation.
Gao MG; Hong Y; Qin YZ; Chang YJ; Wang Y; Zhang XH; Xu LP; Huang XJ; Zhao XS
Medicine (Baltimore); 2020 Dec; 99(50):e23569. PubMed ID: 33327316
[TBL] [Abstract][Full Text] [Related]
8. Determining the Appropriate Treatment for T-Cell Acute Lymphoblastic Leukemia With
Lin N; Liu Z; Li Y; Yan X; Wang L
Front Oncol; 2021; 11():651494. PubMed ID: 33869055
[No Abstract] [Full Text] [Related]
9. A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Zahler S; Bhatia M; Ricci A; Roy S; Morris E; Harrison L; van de Ven C; Fabricatore S; Wolownik K; Cooney-Qualter E; Baxter-Lowe LA; Luisi P; Militano O; Kletzel M; Cairo MS
Biol Blood Marrow Transplant; 2016 Apr; 22(4):698-704. PubMed ID: 26785332
[TBL] [Abstract][Full Text] [Related]
10. SET-CAN/NUP214 fusion gene in leukemia: general features and clinical advances.
Song J; Li H; Fan S
Front Oncol; 2023; 13():1269531. PubMed ID: 37909026
[No Abstract] [Full Text] [Related]
11. [Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Gao MG; Fu Q; Qin YZ; Chang YJ; Wang Y; Yan CH; Xu LP; Zhang XH; Huang XJ; Zhao XS
Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):868-874. PubMed ID: 34551474
[No Abstract] [Full Text] [Related]
12. Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases.
Fang H; Yabe M; Zhang X; Kim Y; Wu X; Wei P; Chi S; Zheng L; Garcia-Manero G; Shao L; Yuan J; Shen Y; Zheng G; Tang G; Wang W; Loghavi S; Shen Q; Yuan Y; He R; Chen D; Medeiros LJ; Hu S
Mod Pathol; 2021 Jun; 34(6):1143-1152. PubMed ID: 33558656
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of 7 cases of pediatric acute myeloid leukemia with DEK-NUP214 fusion gene].
Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY
Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983
[No Abstract] [Full Text] [Related]
14. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia.
Fleischmann M; Scholl S; Frietsch JJ; Hilgendorf I; Schrenk K; Hammersen J; Prims F; Thiede C; Hochhaus A; Schnetzke U
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3191-3202. PubMed ID: 35099591
[TBL] [Abstract][Full Text] [Related]
16. The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.
Schlenk RF; Taskesen E; van Norden Y; Krauter J; Ganser A; Bullinger L; Gaidzik VI; Paschka P; Corbacioglu A; Göhring G; Kündgen A; Held G; Götze K; Vellenga E; Kuball J; Schanz U; Passweg J; Pabst T; Maertens J; Ossenkoppele GJ; Delwel R; Döhner H; Cornelissen JJ; Döhner K; Löwenberg B
Blood; 2013 Aug; 122(9):1576-82. PubMed ID: 23863898
[TBL] [Abstract][Full Text] [Related]
17. A Case of Acute Myeloid Leukemia with Myelodysplasia-Related Changes, SET-NUP214 Fusion, and Complex Karyotype.
Chang SH
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546746
[TBL] [Abstract][Full Text] [Related]
18. Case Report: The First Report of
Wang HP; He JJ; Zhu QY; Wang L; Li JH; Huang JS; Xie WZ; Zhu HH; Jin J
Front Oncol; 2021; 11():706798. PubMed ID: 34307175
[TBL] [Abstract][Full Text] [Related]
19. B-cell acute lymphoblastic leukemia associated with SET-NUP214 rearrangement: A case report and review of the literature.
Zhu HH; Zhao XS; Qin YZ; Lai YY; Jiang H
Oncol Lett; 2016 Apr; 11(4):2644-2650. PubMed ID: 27073532
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
